Perivoli Innovations

Perivoli Innovations operates as the commercial arm and wholly owned subsidiary of the Perivoli Foundation, a UK-registered charity. Established with a distinct mission, the firm focuses on identifying, nurturing, and commercializing early-stage technologies that demonstrate significant potential for both societal and economic impact. Their investment scope is specifically directed towards innovations within critical sectors, including medical, life science, climate science, and digital technologies. This unique structure allows Perivoli Innovations to blend philanthropic objectives with a venture-style approach to technology development and market entry.

The firm primarily targets seed and early-stage companies, often sourcing opportunities from university spin-outs and research institutions. Perivoli Innovations distinguishes itself by offering more than just capital; it provides comprehensive strategic guidance and operational support to help these nascent innovations successfully transition from the research phase to viable market solutions. Their hands-on approach aims to mitigate the inherent risks associated with deep technology commercialization, fostering growth and ensuring that promising scientific advancements can achieve their full potential.

Evidencing their commitment to early-stage funding, Perivoli Innovations has actively participated in and led various funding rounds. For instance, the firm led a significant £1.5 million seed round for Phytoform Labs, a clear indicator of their capacity to anchor substantial early investments. They have also been a participant in other notable seed rounds, such as the £2.6 million raise for Oxford Diagnostics (OxDX), further solidifying their presence in the UK's deep tech ecosystem. Based on their investment patterns and stated focus, Perivoli Innovations typically deploys first cheques ranging from approximately $500,000 to $2,000,000, with a readiness to provide follow-on capital as portfolio companies mature.

This strategic investor's alignment with a charitable foundation provides a unique lens through which investments are evaluated, prioritizing long-term impact alongside financial returns. Perivoli Innovations is positioned as a patient capital provider, committed to supporting groundbreaking technologies that can address pressing global challenges, thereby contributing to both commercial success and broader societal good.